These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38864473)

  • 1. A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection.
    Xie Q; Zhao Z; Yang Y; Wang X; Wu W; Jiang H; Hao W; Peng R; Luo C
    Cancer Med; 2024 Jun; 13(11):e7374. PubMed ID: 38864473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
    Yan X; Li Y; Qin W; Liao J; Fan J; Xie Y; Wang Z; Li S; Liao W
    BMC Cancer; 2024 Jun; 24(1):700. PubMed ID: 38849749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis.
    Qian GX; Xu ZL; Li YH; Lu JL; Bu XY; Wei MT; Jia WD
    World J Gastroenterol; 2024 Apr; 30(15):2128-2142. PubMed ID: 38681988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based clinical-radiomics nomogram model for predicting microvascular invasion in hepatocellular carcinoma.
    Wang Q; Zhou Y; Yang H; Zhang J; Zeng X; Tan Y
    Med Phys; 2024 Jul; 51(7):4673-4686. PubMed ID: 38642400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection.
    Xie Q; Zhao Z; Yang Y; Long D; Luo C
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14983-14996. PubMed ID: 37606762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
    Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
    Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
    Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
    Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
    Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
    Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
    Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
    Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
    Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
    Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
    World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive radiopathological nomogram for the prediction of pathological staging in gastric cancer using CT-derived and WSI-based features.
    Tan Y; Feng LJ; Huang YH; Xue JW; Long LL; Feng ZB
    Transl Oncol; 2024 Feb; 40():101864. PubMed ID: 38141376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction power of radiomics in early recurrence of hepatocellular carcinoma: A systematic review and meta-analysis.
    Hu Y; Zhang L; Zhang H; Zhang B; Yang J; Li R
    Medicine (Baltimore); 2024 Jul; 103(27):e38721. PubMed ID: 38968499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment.
    Wang G; Ding F; Chen K; Liang Z; Han P; Wang L; Cui F; Zhu Q; Cheng Z; Chen X; Huang C; Cheng H; Wang X; Zhao X
    J Transl Med; 2024 Sep; 22(1):683. PubMed ID: 39218938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
    Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.